Skip to main content
. Author manuscript; available in PMC: 2020 Jun 29.
Published in final edited form as: J Alzheimers Dis. 2020;73(1):77–86. doi: 10.3233/JAD-190438

Table 1.

Patient Characteristics Overall and by Site

Overall (n = 220)
n (%)
Site A (n = 109)
n (%)
Site B (n = 111)
n (%)
χ2 p

Diagnosis (n = 220)
 Probable AD 139 (63.18) 72 (66.06) 67 (60.36)
 Possible AD 49 (22.27) 14 (12.84) 35 (31.53)
 Mixed AD 32 (14.55) 23 (21.10) 9 (8.11) 15.29 <0.001*
Patient Gender (n = 220)
 Female 120 (54.55) 51 (46.79) 69 (62.16)
 Male 100 (45.45) 58 (53.21) 42 (37.84) 5.24 0.022*
Caregiver Gender (n = 201)
 Female 137 (68.16) 71 (65.14) 66 (71.74)
 Male 64 (31.84) 38 (34.86) 26 (28.26) 1.00 0.317
Caregivera (n = 218)
 Spouse or Spouse Equivalent 118 (54.13) 77 (70.64) 41 (37.61)
 Other Family Member/Relative 91 (41.74) 30 (27.52) 61 (55.96)
 Other 9 (4.13) 2 (1.83) 7 (6.42) <0.001*
Marital Status (n = 214)
 Married 144 (67.29) 82 (78.10) 62 (56.88)
 Other 70 (32.71) 23 (21.90) 47 (43.12) 10.94 0.001*
Ethnicity (n = 220)
 Caucasian 171 (77.73) 83 (76.15) 88 (79.28)
 Non-Caucasian 49 (22.27) 26 (23.85) 23 (20.72) 0.31 0.577

Mean (SD) Mean (SD) Mean (SD) Zb p

Age (n = 220) 79.04 (6.96) 79.33 (7.14) 78.76 (6.80) 0.63 0.527
Age at symptom onset (n = 216) 72.74 (7.82) 73.11 (8.29) 72.36 (7.33) −0.09 0.356
Education, years (n = 220) 13.90 (3.39) 15.04 (2.95) 12.78 (3.44) 5.02 <0.001*
MMSE (n = 203) 19.99 (6.10) 19.55 (6.23) 20.41 (5.98) −1.06 0.229
BRDRS (n = 211) 5.00 (3.57) 5.30 (3.49) 4.69 (3.65) −1.63 0.103
Comorbid Conditions (n = 214) 3.02 (1.73) 3.70 (1.70) 2.37 (1.51) 5.77 <0.001*
Medication Count (n = 214) 6.27 (3.72) 6.58 (4.04) 5.96 (3.38) 0.87 0.382

SD, standard deviation; MMSE, Mini-Mental State Examination; BRDRS, Blessed Roth Dementia Rating Scale.

a

Fisher’s Exact Test

b

Wilcoxon Rank Sum Test

*

p < 0.05.